PON1 status and homocysteine levels as potential biomarkers for cardiovascular disease
Sign Up to like & getrecommendations! Published in 2020 at "Experimental Gerontology"
DOI: 10.1016/j.exger.2020.111062
Abstract: BACKGROUND Cardiovascular disease (CVD) is the leading cause of death. The mainly risks factors for CVD are diabetes, hypertension and high levels of homocysteine (Hcys), among others. Paraoxonase 1 (PON1) has been proposed as an… read more here.
Keywords: pon1; cardiovascular disease; hcys; pon1 concentration ... See more keywords
Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia
Sign Up to like & getrecommendations! Published in 2017 at "Free Radical Biology and Medicine"
DOI: 10.1016/j.freeradbiomed.2017.02.027
Abstract: Abstract NADPH oxidase (NOX)‐derived reactive oxygen species (ROS) have been demonstrated to mediate the activation of NOD‐like receptor protein 3 (NLRP3) inflammasomes in podocytes in response to elevated levels of homocysteine (Hcys). However, it remains… read more here.
Keywords: vav2; inflammasome activation; hcys; activation ... See more keywords
Homocysteine Is a Marker of Increased Cardio-Cerebrovascular Disease Risk in Psoriatic Patients, but It Does Not Reflect the Effect of Biological Therapy in the Longitudinal Observation
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Clinical Practice"
DOI: 10.1155/2022/3820094
Abstract: Background Psoriasis is linked to atherosclerosis. Homocysteine (HCYS) has been identified as a marker of increased risk of cardio-cerebrovascular diseases (CCVD) in population. Objective The aim of the study was to determine whether elevated HCYS… read more here.
Keywords: marker increased; biological therapy; elevated hcys; risk ... See more keywords